HIGHLIGHTS
- who: Xiaoni Gao and collaborators from the Faculty of Medicine, The University of Queensland, Australia have published the paper: Immunotherapy or targeted therapy: What will be the future treatment for anaplastic thyroid carcinoma?, in the Journal: (JOURNAL) of April/30,/2019
- what: The study recruited a total of four ATC patients, and the results of the study showed that only one ATC patient achieved SD. December 2022 MLN0128 II phase Active, not recruiting Sorafenib II phase Unknown This study attempted to apply it to preoperative treatment of undifferentiated cancer to see if it would shrink . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.